Fatro
Prinovox 100 mg + 25 mg - cani tra 4 e 10 kg - 6 pipette

Il trattamento di pulci e zecche infestazioni in cani e gatti

Prescrizione obbligatoria* (Si applicano eccezioni)

Si prega di osservare!  ()

Il testo che segue è stato tradotto automaticamente da Google Translate. Esso potrebbe non essere pienamente comprensibile e contenere errori e informazioni inaffidabili.
La nostra redazione sta attualmente scrivendo e correggendo tutte le schede tecniche dei prodotti nella tua lingua. Tutti i contenuti e le informazioni relative al prodotto saranno presto disponibili nella tua lingua.
Grazie per la pazienza e comprensione.

Descrizione:

Prinovox è una soluzione limpida, di colore giallo al marrone spot-on per gatti, furetti e cani.

Ingredienti:

Ogni Prinovox pipetta contiene:

Principio attivo:




Nome
imidacloprid
moxidectin




Prinovox 40 mg + soluzione spot-on 4 mg per i piccoli gatti e furetti
40.00 mg
4,0 mg


Prinovox 40 mg + soluzione spot-on 10 mg per cani di piccola taglia
40.00 mg
10,0 mg


Prinovox 80 mg + soluzione spot-on 8 mg per grandi gatti
80.00 mg
8,0 mg


Prinovox 100 mg + soluzione spot-on 25 mg per cani di media
100,00 mg
25.0 mg


Prinovox 250 mg + 62,5 soluzione spot-on mg per cani di taglia grande
250,00 mg
62,5 mg


Prinovox 400 mg + 100 soluzione spot-on mg per cani molto grandi
400,00 mg
100,0 mg




Elenco degli eccipienti:

Butilidrossitoluene (E 321)
Alcool benzilico
carbonato di propilene



indicazioni:

Indicazioni per l'uso di Prinovox , specificando le specie di destinazione:

Per i gatti affetti da, oa rischio di, infestazioni parassitarie miste:

Il trattamento e la prevenzione delle infestazioni da pulci (Ctenocephalides felis)
Il trattamento di acari dell'orecchio (Otodectes cynotis)
Il trattamento della rogna notoedric (Notoedres cati)
Il trattamento dei aerophilus lungworm Eucoleus (sin. Capillaria aerophila)
(adulti).
La prevenzione della filariosi cardiopolmonare (L3 e L4 di Dirofilaria immitis)
Il trattamento delle infezioni da nematodi gastrointestinali (L4
adulti immaturi e adulti di Toxocara cati e Ancylostoma tubaeforme).
The product can be used as part of a treatment strategy for flea allergy
dermatitis (FAD).

For ferrets suffering from, or at risk from, mixed parasitic infections:

Treatment and prevention of flea infestation (Ctenocephalides felis)
The prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).

For dogs suffering from, or at risk from, mixed parasitic infections:

The treatment and prevention of flea infestation (Ctenocephalides felis)
The treatment of biting lice (Trichodectes canis)
The treatment of ear mite infestation (Otodectes cynotis), sarcoptic mange
(caused by Sarcoptes scabiei var. canis), demodicosis (caused by Demodex
canis)
The prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis)
The treatment of circulating microfilariae (Dirofilaria immitis),
The treatment of cutaneous dirofilariosis (adult stages of Dirofilaria repens)
The prevention of cutaneous dirofilariosis (L3 larvae of Dirofilaria repens)
The reduction of circulating microfilariae (Dirofilaria repens)
The prevention of angiostrongylosis (L4 larvae and immature adults of
Angiostrongylus vasorum),
The treatment of Angiostrongylus vasorum and Crenosoma vulpis
The prevention of spirocercosis (Spirocerca lupi)
The treatment of Eucoleus (syn. Capillaria) boehmi (adults)
The treatment of the eye worm Thelazia callipaeda (adults)
The treatment of infections with gastrointestinal nematodes (L4 larvae,
immature adults and adults of Toxocara canis, Ancylostoma caninum and
Uncinaria stenocephala, adults of Toxascaris leonina and Trichuris vulpis).
The product can be used as part of a treatment strategy for flea allergy
dermatitis (FAD).

Non usare in gattini sotto le 9 settimane di età.
Non utilizzare nei cuccioli sotto le 7 settimane di età.
Non usare in caso di ipersensibilità nota ai principi attivi o ad uno qualsiasi dei
eccipienti.
Non usare in cani classificati come classe 4 per la filariosi cardiopolmonare, come la sicurezza del
prodotto non è stato valutato in questo gruppo animale.
Per furetti: non usare Prinovox per grandi gatti (0,8 ml) o Prinovox per i cani (di qualsiasi dimensione).
Per i cani, il prodotto corrispondente “Prinovox per cani”, che contiene 100 mg / ml
imidacloprid e 25 mg / ml di moxidectin, deve essere utilizzato.
Non utilizzare su canarini.


Dosaggio:

Gli importi di Prinovox da somministrare e via di somministrazione:

Solo per uso esterno.
Il peso corporeo di animali trattati deve essere determinato prima del trattamento.
Lo schema di trattamento deve essere basato sulla diagnosi veterinaria individuale e sulla
local epidemiological situation.
Method of administration:

Remove one pipette from the package. Then hold the pipette in an upright position,
and twist and pull off the cap. Reverse the cap and use it to twist and remove the
seal from the pipette.
Cats and ferrets:
Part the fur on the animal's neck at the base of the skull until the skin is visible. Application at the base of the skull will minimise the opportunity for the animal to lick the product.
Dogs:
With the animal in a standing position, part the coat between the shoulder blades until the skin is visible.
Place the tip of the pipette on the skin and squeeze the pipette firmly several times to
empty its contents directly onto the skin. Apply only to undamaged
skin.


Dosage schedule for cats:

The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 1.0 mg/kg bodyweight moxidectin, equivalent to 0.1 ml of this product per kg bodyweight.




Weight of cat [kg]
Pipette size to be used
Volume [ml]
Imidacloprid [mg/kg bw]
Moxidectin [mg/kg bw]




≤ 4 kg
Prinovox for small cats and ferrets
0.4
minimum of 10
minimum of 1


> 4–8 kg
Prinovox for large cats
0.8
10–20
1–2


> 4–8 kg
The appropriate combination of pipettes




Flea treatment and prevention (Ctenocephalides felis):

One treatment prevents future flea infestation for 4 weeks. Existing pupae in the environment may emerge for 6 weeks or longer after treatment is initiated, depending upon climatic conditions. Therefore, it may be necessary to combine the treatment with this product with environmental treatments aimed at breaking the flea life cycle in the surroundings. This can result in a more rapid reduction in the household flea population. The product should be administered at monthly intervals when used as part of a treatment strategy for flea allergy.

Treatment of ear mite infestation (Otodectes cynotis):

A single dose of the product should be administered. A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment. Do not apply directly to the ear canal.

Treatment of notoedric mange (Notoedres cati):

A single dose of the product should be administered.

Treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults):

A single dose of the product should be administered.

Heartworm prevention (Dirofilaria immitis):

Cats in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to treatment with this product.
For prevention of heartworm disease, the product must be applied at regular monthly intervals during the time of the year when mosquitoes (the intermediate hosts which carry and transmit heartworm larvae) are present. The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes. Treatment should continue at regular monthly intervals until 1 month after the last exposure to mosquitoes. To establish a treatment routine, it is recommended that the same day or date be used each month. When replacing another heartworm preventative product in a heartworm prevention programme, the first treatment with this product must be given within 1 month of the last dose of the former medication.
In non-endemic areas there should be no risk of cats having heartworm. Therefore they can be treated without special precautions.

Roundworm and hookworm treatment:

In areas endemic for heartworm, monthly treatment may significantly reduce the risk of re-infection caused by the respective roundworms and hookworms. In areas nonendemic for heartworm, the product can be used as part of a seasonal prevention programme against fleas and gastrointestinal nematodes.


Dosage schedule for ferrets:

One 0.4 ml pipette of this product should be administered per animal. Do not exceed the recommended dose. The treatment schedule should be based on the local epidemiological situation.
Flea treatment and prevention (Ctenocephalides felis):

One treatment prevents future flea infestation for 3 weeks. Under heavy flea pressure it may be necessary to repeat administration after 2 weeks.

Heartworm prevention (Dirofilaria immitis):

Ferrets in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to treatment with this product, the advice provided in section 4.5 should be considered.
For prevention of heartworm disease, the product must be applied at regular monthly intervals during the time of the year when mosquitoes (the intermediate hosts which carry and transmit heartworm larvae) are present. The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes. Treatment should continue at regular monthly intervals until 1 month after the last exposure to mosquitoes.
In non-endemic areas there should be no risk of ferrets having heartworm. Therefore they can be treated without special precautions.


Dosage schedule for dogs:

The recommended minimum doses are 10 mg/kg bodyweight imidacloprid and 2.5 mg/kg bodyweight moxidectin, equivalent to 0.1 ml of this product per kg bodyweight.




Weight of dog [kg]
Pipette size to be used
Volume [ml]
Imidacloprid [mg/kg bw]
Moxidectin [mg/kg bw]




≤ 4 kg
Prinovox for small dogs
0.4
minimum of 10
minimum of 2.5


> 4–10 kg
Prinovox for medium dogs
1.0
10–25
2.5–6.25


> 10–25 kg
Prinovox for large dogs
2.5
10–25
2.5–6.25


> 25–40 kg
Prinovox for extra-large dogs
4.0
10–16
2.5–4


> 40 kg
The appropriate combination of pipettes




Flea treatment and prevention (Ctenocephalides felis):

One treatment prevents future flea infestation for 4 weeks. Existing pupae in the environment may emerge for 6 weeks or longer after treatment is initiated, depending upon climatic conditions. Therefore, it may be necessary to combine the treatment with the product with environmental treatments aimed at breaking the flea life cycle in the surroundings. This can result in a more rapid reduction in the household flea population. The product should be administered at monthly intervals when used as part of a treatment strategy for flea allergy dermatitis.

Treatment of biting lice (Trichodectes canis):

A single dose should be administered. A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment.

Treatment of ear mite infestation (Otodectes cynotis):

A single dose of the product should be administered. Loose debris should be gently removed from the external ear canal at each treatment. A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment. Do not apply directly to the ear canal.

Treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis):

A single dose should be administered twice 4 weeks apart.

Treatment of demodicosis (caused by Demodex canis):

The administration of a single dose every 4 weeks for 2 to 4 months is efficacious against Demodex canis and leads to a marked improvement of clinical signs particularly in mild to moderate cases. Especially severe cases may require more prolonged and more frequent treatment. To achieve the best possible response in these severe cases, at the discretion of the veterinarian, the product can be applied once a week and for a prolonged time. In all cases it is essential that the treatment should be continued until skin scrapings are negative on at least 2 consecutive monthly occasions. Treatment should be stopped in dogs that show no improvement
or do not respond in mite count after 2 months treatment. Alternative treatment should be administered. Seek the advice of your veterinarian.
As demodicosis is a multi-factorial disease, where possible, it is advisable to also treat any underlying disease appropriately.

Prevention of heartworm disease (D. immitis) and cutaneous dirofilariosis (D. repens):

Dogs in areas endemic for heartworm, or those which have travelled to endemic areas, may be infected with adult heartworms. Therefore prior to treatment with this product, the advice provided in section 4.5 should be considered.
For prevention of heartworm disease and cutaneous dirofilariosis, the product must be applied at regular monthly intervals during the time of the year when mosquitoes (the intermediate hosts which carry and transmit D. immitis and D. repens larvae) are present. The product may be administered throughout the year or at least 1 month before the first expected exposure to mosquitoes. Treatment should continue at regular monthly intervals until 1 month after the last exposure to mosquitoes. To establish a treatment routine, it is recommended that the same day or date be used each month. When replacing another heartworm preventative product in a heartworm
prevention programme, the first treatment with this product must be given within 1 month of the last dose of the former medication.
In non-endemic areas there should be no risk of dogs having heartworm. Therefore they can be treated without special precautions.

Treatment of microfilariae (D. immitis):

The product should be administered monthly for two consecutive months.

Treatment of cutaneous dirofilariosis (adult stages of Dirofilaria repens):

The product should be administered monthly for six consecutive months.

Reduction of microfilariae ( D. repens):

The product should be administered monthly for four consecutive months.

Treatment and prevention of Angiostrongylus vasorum:

A single dose should be administered. A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment. In endemic areas regular monthly applications will prevent angiostrongylosis and patent infection with Angiostrongylus vasorum.

Treatment of Crenosoma vulpis

A single dose should be administered.

Prevention of Spirocerca lupi:

The product should be administered monthly.

Treatment of Eucoleus (syn. Capillaria) boehmi (adults)

The product should be administered monthly for two consecutive months. It is advisable to prevent auto-coprophagia between the two treatments in order to prevent possible reinfection.

Treatment of the eye worm Thelazia callipaeda (adults):

A single dose of the product should be administered.

Roundworm, hookworm and whipworm treatment:

In areas endemic for heartworm, monthly treatment may significantly reduce the risk of re-infection caused by the respective round-, hook- and whipworms. In areas nonendemic for heartworm, the product can be used as part of a seasonal prevention programme against fleas and gastrointestinal nematodes.
Studies have shown that monthly treatment of dogs will prevent infections caused by Uncinaria stenocephala.



53.76
67.20 €
Ordina entro 13h 2m 6s (prima delle 12:00)
E ricevi il tuo ordine
con lunedì 28 ottobre
TRASPORTO AEREO

I clienti che acquistano questo prodotto, di solito acquistano anche: